Exact Mass: 365.216

Exact Mass Matches: 365.216

Found 57 metabolites which its exact mass value is equals to given mass value 365.216, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Angiotensin (5-7)

Angiotensin (5-7); Angiotensin-(5-7)

C17H27N5O4 (365.2063)


   

Caroverine

1-[2-(diethylamino)ethyl]-3-[(4-methoxyphenyl)methyl]-1,2-dihydroquinoxalin-2-one

C22H27N3O2 (365.2103)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Nafadotride

Nafadotride

C22H27N3O2 (365.2103)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

   

deoxybrevianamide E

deoxybrevianamide E

C22H27N3O2 (365.2103)


   

11alpha-hydroxyacetylfawcettiine

11alpha-hydroxyacetylfawcettiine

C20H31NO5 (365.2202)


   

5alpha,12-dihydroxy-1-tremulen-11-yl 2(S)-pyroglutamate

5alpha,12-dihydroxy-1-tremulen-11-yl 2(S)-pyroglutamate

C20H31NO5 (365.2202)


   
   
   
   
   
   
   
   
   
   
   
   
   

ALUMINUM CALCIUM ISOPROPOXIDE

ALUMINUM CALCIUM ISOPROPOXIDE

C15H38AlCaO5 (365.216)


   

ALD-52

1-Acetyllysergic acid diethylamide

C22H27N3O2 (365.2103)


   

Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-cyclohexyl- (9CI)

Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-cyclohexyl- (9CI)

C21H27N5O (365.2215)


   
   

3-[4-(Hexyloxy)phenyl]-3-({[(2-methyl-2-propanyl)oxy]carbonyl}ami no)propanoic acid

3-[4-(Hexyloxy)phenyl]-3-({[(2-methyl-2-propanyl)oxy]carbonyl}ami no)propanoic acid

C20H31NO5 (365.2202)


   

1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium acetate

1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium acetate

C22H27N3O2 (365.2103)


   

1-[[4-(2,4,6-Trimethylphenyl)-1-piperazinyl]sulfonyl]azepane

1-[[4-(2,4,6-Trimethylphenyl)-1-piperazinyl]sulfonyl]azepane

C19H31N3O2S (365.2137)


   

2-methyl-N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]propanamide

2-methyl-N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]propanamide

C22H27N3O2 (365.2103)


   

H-Pro-his-leu-OH

H-Pro-his-leu-OH

C17H27N5O4 (365.2063)


   

D-Phenylalanyl-N-(3-Methylbenzyl)-L-Prolinamide

D-Phenylalanyl-N-(3-Methylbenzyl)-L-Prolinamide

C22H27N3O2 (365.2103)


   

Caroverine

1-[2-(diethylamino)ethyl]-3-[(4-methoxyphenyl)methyl]quinoxalin-2-one

C22H27N3O2 (365.2103)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

N-[2-(4-Isobutyryl-piperazin-1-yl)-phenyl]-4-methyl-benzamide

N-[2-(4-Isobutyryl-piperazin-1-yl)-phenyl]-4-methyl-benzamide

C22H27N3O2 (365.2103)


   
   
   
   
   

N-(2-cyclohexylidene-1-phenylethyl)-1,1-diphenylmethanimine

N-(2-cyclohexylidene-1-phenylethyl)-1,1-diphenylmethanimine

C27H27N (365.2143)


   

(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H27N3O2 (365.2103)


   
   
   
   
   
   
   
   
   
   

ST 18:1;O3;Gly

ST 18:1;O3;Gly

C20H31NO5 (365.2202)


   

11α-hydroxy-acetylfawcettine

NA

C20H31NO5 (365.2202)


{"Ingredient_id": "HBIN000348","Ingredient_name": "11\u03b1-hydroxy-acetylfawcettine","Alias": "NA","Ingredient_formula": "C20H31NO5","Ingredient_Smile": "CC1CC23C4CCCN2CCC(C3C(C1OC(=O)C)CC4OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38581","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2r,4as,8s,8as)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol

(1r,2r,4as,8s,8as)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol

C21H32ClNO2 (365.2121)


   

2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid

2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid

C17H27N5O4 (365.2063)


   

2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid

2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid

C17H27N5O4 (365.2063)


   

(1s,2s)-2-{[(1s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid

(1s,2s)-2-{[(1s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid

C17H27N5O4 (365.2063)


   

n-[(1r,4r,4as,8ar)-4-[6-(2-chloropropan-2-yl)-5,6-dihydro-2h-pyran-3-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]carboximidic acid

n-[(1r,4r,4as,8ar)-4-[6-(2-chloropropan-2-yl)-5,6-dihydro-2h-pyran-3-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]carboximidic acid

C21H32ClNO2 (365.2121)


   

[7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl 5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

[7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl 5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

C20H31NO5 (365.2202)


   

(1s,2s)-2-{[(1s,2s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid

(1s,2s)-2-{[(1s,2s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid

C17H27N5O4 (365.2063)


   

[(5r,7r,8s,8ar)-7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

[(5r,7r,8s,8ar)-7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

C20H31NO5 (365.2202)


   

(1r,2r,4as,8s)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol

(1r,2r,4as,8s)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol

C21H32ClNO2 (365.2121)